Comprehensive identification of proteins in Hodgkin lymphoma-derived Reed-Sternberg cells by LC-MS/MS. (Q40079251)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Comprehensive identification of proteins in Hodgkin lymphoma-derived Reed-Sternberg cells by LC-MS/MS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author

Kojo Elenitoba-Johnson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Megan S Lim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Jeremy C Wallentine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ki Kwon Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Charles E Seiler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Cecily P Vaughn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

David K Crockett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sheryl R Tripp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

17 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1113-1124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17876297%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

7 January 2020

liquid chromatography–mass spectrometry

1 reference

liquid chromatography-tandem mass spectrometry

inferred from title

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700672

inferred from title

exact match

0 references

cites work

Epidemiology of lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Hodgkin's disease and the malignant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

A high-throughput approach for subcellular proteome: identification of rat liver proteins using subcellular fractionation coupled with two-dimensional liquid chromatography tandem mass spectrometry and bioinformatic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Proteomics in pathology research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Plasma proteomic pattern as biomarkers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Protein expression pattern distinguishes different lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

An approach to the proteomic analysis of a breast cancer cell line (SKBR-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

A statistical model for identifying proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

GoMiner: a resource for biological interpretation of genomic and proteomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Notch signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Multiple niches for Notch in cancer: context is everything

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Notch signaling in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

IL-9 and its receptor: from signal transduction to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

BRAF mutations in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Prognostic value of ERBB family mRNA expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

The links between axin and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Tenascins: regulation and putative functions during pathological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Tenascins, a growing family of extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

Structure and function of the immune semaphorin CD100/SEMA4D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021

Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021

Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021

L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021

Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021

Mass spectrometry-based proteomic studies of human anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021

Expression of mucin antigens in human cancers and its relationship with malignancy potential

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700672

7 January 2021